Sex differences in cardiologic medication provision for adults with coronary heart disease: an analysis of health claims data from 2018 to 2020 in Saxony-Anhalt, Germany

Background Coronary heart diseases (CHDs) have experienced the largest increase worldwide as a cause of death, accounting for 16% of all deaths. In Saxony-Anhalt, a federal state in Germany, both CHD morbidity and acute myocardial infarction mortality rates are particularly high. Several risk factor...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	BMC health services research Jg. 24; H. 1; S. 288 - 8
Hauptverfasser:	Fleischer, Steffen, Heinrich, Stephanie, Meyer, Gabriele, Mikolajczyk, Rafael, Lückmann, Sara Lena
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	London BioMed Central 06.03.2024 BioMed Central Ltd BMC
Schlagworte:	Adult Adults Cardiologic healthcare Cardiology Cardiovascular agents Coronary Disease - drug therapy Coronary Disease - epidemiology Coronary heart disease Drug therapy Evidence-based medicine Female Germany - epidemiology Health Administration Health care disparities Health care industry Health care reform Health claims data Health Informatics Heart attack Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use Male Medical research Medicine Medicine & Public Health Medicine, Experimental Nursing Research Patient compliance Public Health Quality of healthcare Risk factors Sex Characteristics Sex differences Statins Use of statins Germany Use of statins Cardiologic healthcare Sex differences Health claims data Coronary heart disease Quality of healthcare
ISSN:	1472-6963, 1472-6963
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Abstract	Background Coronary heart diseases (CHDs) have experienced the largest increase worldwide as a cause of death, accounting for 16% of all deaths. In Saxony-Anhalt, a federal state in Germany, both CHD morbidity and acute myocardial infarction mortality rates are particularly high. Several risk factors associated with CHDs have been studied in Saxony-Anhalt, but sex differences in service use and medication have not been investigated. This study therefore aimed to investigate sex differences in the quality and quantity of cardiological care provided to adults with CHD. Methods This study used health claims data from 2018 to 2020 to analyse the utilisation of healthcare services and adherence to medication-related guideline recommendations in primary and specialist care. The sample included 133,661 individuals with CHD from a major statutory health insurance company (Germany). Results Almost all CHD patients (> 99%) received continuous primary care. Continuous cardiologist utilisation was lower for females than for males, with 15.0% and 22.2%, respectively, and sporadic utilisation showed greater differences, with 33.5% of females and 43.4% of males seeking sporadic cardiologist consultations. Additionally, 43.1% of the identified CHD patients participated in disease management programmes (DMPs). The study also examined the impact of DMP participation and cardiologist care on medication uptake and revealed that sex differences in medication uptake, except for statin use, were mitigated by these factors. Statins were prescribed to 42.9% of the CHD patients eligible for statin prescription in accordance with the QiSA indicator for statin prescription eligibility. However, there were significant sex differences in statin utilisation. Female CHD patients were less likely to use statins (35.2%) than male CHD patients were (50.1%). The difference in statin utilisation persisted after adjustment for DMP participation and cardiologist consultation. Conclusions This study highlights sex differences in the utilisation of cardiological healthcare services for patients with CHD in the Saxony-Anhalt cohort. These findings underscore the continuing need for interventions to reduce sex inequalities in accessing healthcare and providing health care for patients with CHD. Factors at the health care system, patient, and physician levels should be further investigated to eventually improve statin prescription in people with CHD, especially women.
AbstractList	Coronary heart diseases (CHDs) have experienced the largest increase worldwide as a cause of death, accounting for 16% of all deaths. In Saxony-Anhalt, a federal state in Germany, both CHD morbidity and acute myocardial infarction mortality rates are particularly high. Several risk factors associated with CHDs have been studied in Saxony-Anhalt, but sex differences in service use and medication have not been investigated. This study therefore aimed to investigate sex differences in the quality and quantity of cardiological care provided to adults with CHD.BACKGROUNDCoronary heart diseases (CHDs) have experienced the largest increase worldwide as a cause of death, accounting for 16% of all deaths. In Saxony-Anhalt, a federal state in Germany, both CHD morbidity and acute myocardial infarction mortality rates are particularly high. Several risk factors associated with CHDs have been studied in Saxony-Anhalt, but sex differences in service use and medication have not been investigated. This study therefore aimed to investigate sex differences in the quality and quantity of cardiological care provided to adults with CHD.This study used health claims data from 2018 to 2020 to analyse the utilisation of healthcare services and adherence to medication-related guideline recommendations in primary and specialist care. The sample included 133,661 individuals with CHD from a major statutory health insurance company (Germany).METHODSThis study used health claims data from 2018 to 2020 to analyse the utilisation of healthcare services and adherence to medication-related guideline recommendations in primary and specialist care. The sample included 133,661 individuals with CHD from a major statutory health insurance company (Germany).Almost all CHD patients (> 99%) received continuous primary care. Continuous cardiologist utilisation was lower for females than for males, with 15.0% and 22.2%, respectively, and sporadic utilisation showed greater differences, with 33.5% of females and 43.4% of males seeking sporadic cardiologist consultations. Additionally, 43.1% of the identified CHD patients participated in disease management programmes (DMPs). The study also examined the impact of DMP participation and cardiologist care on medication uptake and revealed that sex differences in medication uptake, except for statin use, were mitigated by these factors. Statins were prescribed to 42.9% of the CHD patients eligible for statin prescription in accordance with the QiSA indicator for statin prescription eligibility. However, there were significant sex differences in statin utilisation. Female CHD patients were less likely to use statins (35.2%) than male CHD patients were (50.1%). The difference in statin utilisation persisted after adjustment for DMP participation and cardiologist consultation.RESULTSAlmost all CHD patients (> 99%) received continuous primary care. Continuous cardiologist utilisation was lower for females than for males, with 15.0% and 22.2%, respectively, and sporadic utilisation showed greater differences, with 33.5% of females and 43.4% of males seeking sporadic cardiologist consultations. Additionally, 43.1% of the identified CHD patients participated in disease management programmes (DMPs). The study also examined the impact of DMP participation and cardiologist care on medication uptake and revealed that sex differences in medication uptake, except for statin use, were mitigated by these factors. Statins were prescribed to 42.9% of the CHD patients eligible for statin prescription in accordance with the QiSA indicator for statin prescription eligibility. However, there were significant sex differences in statin utilisation. Female CHD patients were less likely to use statins (35.2%) than male CHD patients were (50.1%). The difference in statin utilisation persisted after adjustment for DMP participation and cardiologist consultation.This study highlights sex differences in the utilisation of cardiological healthcare services for patients with CHD in the Saxony-Anhalt cohort. These findings underscore the continuing need for interventions to reduce sex inequalities in accessing healthcare and providing health care for patients with CHD. Factors at the health care system, patient, and physician levels should be further investigated to eventually improve statin prescription in people with CHD, especially women.CONCLUSIONSThis study highlights sex differences in the utilisation of cardiological healthcare services for patients with CHD in the Saxony-Anhalt cohort. These findings underscore the continuing need for interventions to reduce sex inequalities in accessing healthcare and providing health care for patients with CHD. Factors at the health care system, patient, and physician levels should be further investigated to eventually improve statin prescription in people with CHD, especially women. Background Coronary heart diseases (CHDs) have experienced the largest increase worldwide as a cause of death, accounting for 16% of all deaths. In Saxony-Anhalt, a federal state in Germany, both CHD morbidity and acute myocardial infarction mortality rates are particularly high. Several risk factors associated with CHDs have been studied in Saxony-Anhalt, but sex differences in service use and medication have not been investigated. This study therefore aimed to investigate sex differences in the quality and quantity of cardiological care provided to adults with CHD. Methods This study used health claims data from 2018 to 2020 to analyse the utilisation of healthcare services and adherence to medication-related guideline recommendations in primary and specialist care. The sample included 133,661 individuals with CHD from a major statutory health insurance company (Germany). Results Almost all CHD patients (> 99%) received continuous primary care. Continuous cardiologist utilisation was lower for females than for males, with 15.0% and 22.2%, respectively, and sporadic utilisation showed greater differences, with 33.5% of females and 43.4% of males seeking sporadic cardiologist consultations. Additionally, 43.1% of the identified CHD patients participated in disease management programmes (DMPs). The study also examined the impact of DMP participation and cardiologist care on medication uptake and revealed that sex differences in medication uptake, except for statin use, were mitigated by these factors. Statins were prescribed to 42.9% of the CHD patients eligible for statin prescription in accordance with the QiSA indicator for statin prescription eligibility. However, there were significant sex differences in statin utilisation. Female CHD patients were less likely to use statins (35.2%) than male CHD patients were (50.1%). The difference in statin utilisation persisted after adjustment for DMP participation and cardiologist consultation. Conclusions This study highlights sex differences in the utilisation of cardiological healthcare services for patients with CHD in the Saxony-Anhalt cohort. These findings underscore the continuing need for interventions to reduce sex inequalities in accessing healthcare and providing health care for patients with CHD. Factors at the health care system, patient, and physician levels should be further investigated to eventually improve statin prescription in people with CHD, especially women. Background Coronary heart diseases (CHDs) have experienced the largest increase worldwide as a cause of death, accounting for 16% of all deaths. In Saxony-Anhalt, a federal state in Germany, both CHD morbidity and acute myocardial infarction mortality rates are particularly high. Several risk factors associated with CHDs have been studied in Saxony-Anhalt, but sex differences in service use and medication have not been investigated. This study therefore aimed to investigate sex differences in the quality and quantity of cardiological care provided to adults with CHD. Methods This study used health claims data from 2018 to 2020 to analyse the utilisation of healthcare services and adherence to medication-related guideline recommendations in primary and specialist care. The sample included 133,661 individuals with CHD from a major statutory health insurance company (Germany). Results Almost all CHD patients (> 99%) received continuous primary care. Continuous cardiologist utilisation was lower for females than for males, with 15.0% and 22.2%, respectively, and sporadic utilisation showed greater differences, with 33.5% of females and 43.4% of males seeking sporadic cardiologist consultations. Additionally, 43.1% of the identified CHD patients participated in disease management programmes (DMPs). The study also examined the impact of DMP participation and cardiologist care on medication uptake and revealed that sex differences in medication uptake, except for statin use, were mitigated by these factors. Statins were prescribed to 42.9% of the CHD patients eligible for statin prescription in accordance with the QiSA indicator for statin prescription eligibility. However, there were significant sex differences in statin utilisation. Female CHD patients were less likely to use statins (35.2%) than male CHD patients were (50.1%). The difference in statin utilisation persisted after adjustment for DMP participation and cardiologist consultation. Conclusions This study highlights sex differences in the utilisation of cardiological healthcare services for patients with CHD in the Saxony-Anhalt cohort. These findings underscore the continuing need for interventions to reduce sex inequalities in accessing healthcare and providing health care for patients with CHD. Factors at the health care system, patient, and physician levels should be further investigated to eventually improve statin prescription in people with CHD, especially women. Keywords: Sex differences, Quality of healthcare, Coronary heart disease, Cardiologic healthcare, Health claims data, Use of statins Coronary heart diseases (CHDs) have experienced the largest increase worldwide as a cause of death, accounting for 16% of all deaths. In Saxony-Anhalt, a federal state in Germany, both CHD morbidity and acute myocardial infarction mortality rates are particularly high. Several risk factors associated with CHDs have been studied in Saxony-Anhalt, but sex differences in service use and medication have not been investigated. This study therefore aimed to investigate sex differences in the quality and quantity of cardiological care provided to adults with CHD. This study used health claims data from 2018 to 2020 to analyse the utilisation of healthcare services and adherence to medication-related guideline recommendations in primary and specialist care. The sample included 133,661 individuals with CHD from a major statutory health insurance company (Germany). Almost all CHD patients (> 99%) received continuous primary care. Continuous cardiologist utilisation was lower for females than for males, with 15.0% and 22.2%, respectively, and sporadic utilisation showed greater differences, with 33.5% of females and 43.4% of males seeking sporadic cardiologist consultations. Additionally, 43.1% of the identified CHD patients participated in disease management programmes (DMPs). The study also examined the impact of DMP participation and cardiologist care on medication uptake and revealed that sex differences in medication uptake, except for statin use, were mitigated by these factors. Statins were prescribed to 42.9% of the CHD patients eligible for statin prescription in accordance with the QiSA indicator for statin prescription eligibility. However, there were significant sex differences in statin utilisation. Female CHD patients were less likely to use statins (35.2%) than male CHD patients were (50.1%). The difference in statin utilisation persisted after adjustment for DMP participation and cardiologist consultation. This study highlights sex differences in the utilisation of cardiological healthcare services for patients with CHD in the Saxony-Anhalt cohort. These findings underscore the continuing need for interventions to reduce sex inequalities in accessing healthcare and providing health care for patients with CHD. Factors at the health care system, patient, and physician levels should be further investigated to eventually improve statin prescription in people with CHD, especially women. Coronary heart diseases (CHDs) have experienced the largest increase worldwide as a cause of death, accounting for 16% of all deaths. In Saxony-Anhalt, a federal state in Germany, both CHD morbidity and acute myocardial infarction mortality rates are particularly high. Several risk factors associated with CHDs have been studied in Saxony-Anhalt, but sex differences in service use and medication have not been investigated. This study therefore aimed to investigate sex differences in the quality and quantity of cardiological care provided to adults with CHD. This study used health claims data from 2018 to 2020 to analyse the utilisation of healthcare services and adherence to medication-related guideline recommendations in primary and specialist care. The sample included 133,661 individuals with CHD from a major statutory health insurance company (Germany). Almost all CHD patients (> 99%) received continuous primary care. Continuous cardiologist utilisation was lower for females than for males, with 15.0% and 22.2%, respectively, and sporadic utilisation showed greater differences, with 33.5% of females and 43.4% of males seeking sporadic cardiologist consultations. Additionally, 43.1% of the identified CHD patients participated in disease management programmes (DMPs). The study also examined the impact of DMP participation and cardiologist care on medication uptake and revealed that sex differences in medication uptake, except for statin use, were mitigated by these factors. Statins were prescribed to 42.9% of the CHD patients eligible for statin prescription in accordance with the QiSA indicator for statin prescription eligibility. However, there were significant sex differences in statin utilisation. Female CHD patients were less likely to use statins (35.2%) than male CHD patients were (50.1%). The difference in statin utilisation persisted after adjustment for DMP participation and cardiologist consultation. This study highlights sex differences in the utilisation of cardiological healthcare services for patients with CHD in the Saxony-Anhalt cohort. These findings underscore the continuing need for interventions to reduce sex inequalities in accessing healthcare and providing health care for patients with CHD. Factors at the health care system, patient, and physician levels should be further investigated to eventually improve statin prescription in people with CHD, especially women. Abstract Background Coronary heart diseases (CHDs) have experienced the largest increase worldwide as a cause of death, accounting for 16% of all deaths. In Saxony-Anhalt, a federal state in Germany, both CHD morbidity and acute myocardial infarction mortality rates are particularly high. Several risk factors associated with CHDs have been studied in Saxony-Anhalt, but sex differences in service use and medication have not been investigated. This study therefore aimed to investigate sex differences in the quality and quantity of cardiological care provided to adults with CHD. Methods This study used health claims data from 2018 to 2020 to analyse the utilisation of healthcare services and adherence to medication-related guideline recommendations in primary and specialist care. The sample included 133,661 individuals with CHD from a major statutory health insurance company (Germany). Results Almost all CHD patients (> 99%) received continuous primary care. Continuous cardiologist utilisation was lower for females than for males, with 15.0% and 22.2%, respectively, and sporadic utilisation showed greater differences, with 33.5% of females and 43.4% of males seeking sporadic cardiologist consultations. Additionally, 43.1% of the identified CHD patients participated in disease management programmes (DMPs). The study also examined the impact of DMP participation and cardiologist care on medication uptake and revealed that sex differences in medication uptake, except for statin use, were mitigated by these factors. Statins were prescribed to 42.9% of the CHD patients eligible for statin prescription in accordance with the QiSA indicator for statin prescription eligibility. However, there were significant sex differences in statin utilisation. Female CHD patients were less likely to use statins (35.2%) than male CHD patients were (50.1%). The difference in statin utilisation persisted after adjustment for DMP participation and cardiologist consultation. Conclusions This study highlights sex differences in the utilisation of cardiological healthcare services for patients with CHD in the Saxony-Anhalt cohort. These findings underscore the continuing need for interventions to reduce sex inequalities in accessing healthcare and providing health care for patients with CHD. Factors at the health care system, patient, and physician levels should be further investigated to eventually improve statin prescription in people with CHD, especially women.
ArticleNumber	288
Audience	Academic
Author	Fleischer, Steffen Meyer, Gabriele Heinrich, Stephanie Mikolajczyk, Rafael Lückmann, Sara Lena
Author_xml	– sequence: 1 givenname: Steffen surname: Fleischer fullname: Fleischer, Steffen email: steffen.fleischer@medizin.uni-halle.de organization: Martin-Luther-University Halle Wittenberg, Medical Faculty, Institute of Nursing and Health Science – sequence: 2 givenname: Stephanie surname: Heinrich fullname: Heinrich, Stephanie organization: AOK Sachsen-Anhalt – sequence: 3 givenname: Gabriele surname: Meyer fullname: Meyer, Gabriele organization: Martin-Luther-University Halle Wittenberg, Medical Faculty, Institute of Nursing and Health Science – sequence: 4 givenname: Rafael surname: Mikolajczyk fullname: Mikolajczyk, Rafael organization: Martin-Luther-University Halle Wittenberg, Medical Faculty, Institute of Medical Epidemiology Biometrics and Informatics – sequence: 5 givenname: Sara Lena surname: Lückmann fullname: Lückmann, Sara Lena organization: Martin-Luther-University Halle Wittenberg, Medical Faculty, Institute of Medical Epidemiology Biometrics and Informatics
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/38448928$$D View this record in MEDLINE/PubMed
BookMark	eNp9kl1rFDEUhgep2A_9A15IwBsvnDr5mJmMN7IUrYWCF9XrcDZzsptlJlmT2dr9Sf5Lz3Zr6YJIAjkkz_smJ7ynxVGIAYviNa_OOdfNh8xFx2VZCVXyqhVtqZ4VJ1y1omy6Rh49qY-L05xXVcVbLdoXxbHUSulO6JPi9w3esd47hwmDxcx8YBZS7-MQF96yEXtvYfIxsHWKtz7vKhcTg34zTJn98tOS2ZhigLRlS4Q0kV1GyPiRQaAJwzb7zKLbnQ47egA_ZtbDBMylODJRcc2mSKuodvffwF0M23IWlsS_Z5eYRgjbl8VzB0PGVw_rWfHjy-fvF1_L62-XVxez69LWkk-lEGpuAUED8qZXyjbQCbRaSj3vpevavqXmEVxtQc87Egne1Vg1shausVyeFVd73z7CyqyTH6kzE8Gb-42YFoaa9HZAU8-7unXAUTagsFJzV-uuBiFl31pwLXl92nutN3P6SYthSjAcmB6eBL80i3hreNXxhr6DHN49OKT4c4N5MqPPFocBAsZNNqJTguu6UQ2hb_foAuhtPrhIlnaHm1lLSCW51kSd_4Oi0ePoLQXMedo_ELx52sPj4_9miACxB2yKOSd0jwivzC6oZh9UQ0E190E1ikRyL8oEhwUms4qbRGHJ_1P9ASr567Q
Cites_doi	10.1161/CIRCOUTCOMES.116.002781 10.1136/bmj.39202.397488.AD 10.3389/fcvm.2022.929020 10.1161/CIRCULATIONAHA.108.825133 10.1001/jamanetworkopen.2021.13186 10.1136/bmjopen-2017-020437 10.1093/eurjpc/zwaa144 10.1016/S0140-6736(11)61215-4 10.1016/S0140-6736(21)00684-X 10.1016/j.atherosclerosis.2016.01.018 10.1371/journal.pone.0155228 10.3389/fcvm.2018.00158 10.1007/s00392-019-01444-8 10.1136/bmj.39202.399942.AD 10.1016/j.cpcardiol.2022.101329 10.1161/CIRCOUTCOMES.118.005562 10.1016/S0140-6736(20)31561-0 10.1161/JAHA.119.014742 10.3390/diagnostics10070483 10.1001/jama.2022.12567 10.1186/s12872-020-01832-3 10.1007/s11606-022-07595-1 10.1016/j.zefq.2020.11.009 10.1186/s12963-015-0060-2 10.1007/s00103-016-2493-6
ContentType	Journal Article
Copyright	The Author(s) 2024 2024. The Author(s). COPYRIGHT 2024 BioMed Central Ltd.
Copyright_xml	– notice: The Author(s) 2024 – notice: 2024. The Author(s). – notice: COPYRIGHT 2024 BioMed Central Ltd.
DBID	C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM DOA
DOI	10.1186/s12913-024-10727-4
DatabaseName	Springer Nature OA/Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals
DatabaseTitle	CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic
DatabaseTitleList	MEDLINE - Academic MEDLINE
Database_xml	– sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Medicine Public Health
EISSN	1472-6963
EndPage	8
ExternalDocumentID	oai_doaj_org_article_5b957fa1e36a4e04bf5895a233d7caf7 PMC10916020 A785603188 38448928 10_1186_s12913_024_10727_4
Genre	Journal Article
GeographicLocations	Germany
GeographicLocations_xml	– name: Germany
GrantInformation_xml	– fundername: Martin-Luther-Universität Halle-Wittenberg (1043)
GroupedDBID	--- 0R~ 23N 2WC 44B 53G 5VS 6J9 6PF 7RV 7WY 7X7 88E 8FI 8FJ 8FL AAFWJ AAJSJ AASML AAWTL ABDBF ABUWG ACGFO ACGFS ACIHN ACUHS ADBBV ADUKV AEAQA AENEX AFKRA AFPKN AHBYD AHMBA AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BEZIV BFQNJ BMC BPHCQ BVXVI C6C CCPQU CS3 DIK DU5 DWQXO E3Z EAD EAP EAS EBD EBLON EBS EMB EMK EMOBN ESX F5P FRNLG FYUFA GROUPED_DOAJ GX1 HMCUK IAO IHR INH INR ITC K60 K6~ KQ8 M0C M0T M1P M48 M~E NAPCQ O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PJZUB PPXIY PQBIZ PQBZA PQQKQ PROAC PSQYO PUEGO RBZ RNS ROL RPM RSV SMD SOJ SV3 TR2 TUS UKHRP W2D WOQ WOW XSB AAYXX AFFHD CITATION ALIPV CGR CUY CVF ECM EIF NPM 7X8 5PM
ID	FETCH-LOGICAL-c531t-224bcaea8ae16d44c6a92ec8338bd3f97d7844eaf5ca8b9c532195e06352f6c13
IEDL.DBID	RSV
ISICitedReferencesCount	1
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001188161900003&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	1472-6963
IngestDate	Tue Oct 14 19:08:36 EDT 2025 Tue Nov 04 02:05:49 EST 2025 Fri Sep 05 07:45:44 EDT 2025 Sat Nov 29 14:11:58 EST 2025 Sat Nov 29 10:41:52 EST 2025 Mon Jul 21 06:05:21 EDT 2025 Sat Nov 29 02:47:00 EST 2025 Sat Sep 06 07:28:50 EDT 2025
IsDoiOpenAccess	true
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	1
Keywords	Use of statins Cardiologic healthcare Sex differences Health claims data Coronary heart disease Quality of healthcare
Language	English
License	2024. The Author(s). Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c531t-224bcaea8ae16d44c6a92ec8338bd3f97d7844eaf5ca8b9c532195e06352f6c13
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
OpenAccessLink	https://link.springer.com/10.1186/s12913-024-10727-4
PMID	38448928
PQID	2942185646
PQPubID	23479
PageCount	8
ParticipantIDs	doaj_primary_oai_doaj_org_article_5b957fa1e36a4e04bf5895a233d7caf7 pubmedcentral_primary_oai_pubmedcentral_nih_gov_10916020 proquest_miscellaneous_2942185646 gale_infotracmisc_A785603188 gale_infotracacademiconefile_A785603188 pubmed_primary_38448928 crossref_primary_10_1186_s12913_024_10727_4 springer_journals_10_1186_s12913_024_10727_4
PublicationCentury	2000
PublicationDate	2024-03-06
PublicationDateYYYYMMDD	2024-03-06
PublicationDate_xml	– month: 03 year: 2024 text: 2024-03-06 day: 06
PublicationDecade	2020
PublicationPlace	London
PublicationPlace_xml	– name: London – name: England
PublicationTitle	BMC health services research
PublicationTitleAbbrev	BMC Health Serv Res
PublicationTitleAlternate	BMC Health Serv Res
PublicationYear	2024
Publisher	BioMed Central BioMed Central Ltd BMC
Publisher_xml	– name: BioMed Central – name: BioMed Central Ltd – name: BMC
References	10727_CR21 P Raeisi-Giglou (10727_CR33) 2022; 47 A Stang (10727_CR8) 2014; 111 M Zhao (10727_CR14) 2020; 9 SS Dhruva (10727_CR25) 2022; 37 10727_CR26 NL Cook (10727_CR24) 2009; 119 10727_CR27 F Rea (10727_CR39) 2021; 4 MG Nanna (10727_CR29) 2019; 12 H Zhang (10727_CR40) 2016; 11 M Kip (10727_CR17) 2014; 7 B Vogel (10727_CR15) 2021; 397 F Prütz (10727_CR28) 2021; 6 R Aggarwal (10727_CR30) 2022; 328 10727_CR20 TC Vogt (10727_CR7) 2015; 13 S Yusuf (10727_CR31) 2011; 378 10727_CR32 10727_CR11 SS Virani (10727_CR36) 2013; 40 F Mauvais-Jarvis (10727_CR16) 2020; 396 10727_CR18 10727_CR5 J Holstiege (10727_CR22) 2019; 108 10727_CR2 M Kendrick (10727_CR34) 2007; 334 X Wang (10727_CR38) 2022; 9 10727_CR1 10727_CR4 K Fujita (10727_CR19) 2018; 8 SL Lueckmann (10727_CR13) 2021; 160 SV Arnold (10727_CR12) 2016; 9 Z Reiner (10727_CR37) 2016; 246 C Dornquast (10727_CR6) 2018; 5 C Fischer (10727_CR10) 2021; 21 M Hörold (10727_CR3) 2021 P Vynckier (10727_CR23) 2022; 29 SM Grundy (10727_CR35) 2007; 334 C Diederichs (10727_CR9) 2017; 60
References_xml	– volume: 9 start-page: 554 issue: 5 year: 2016 ident: 10727_CR12 publication-title: Circ Cardiovasc Qual Outcomes doi: 10.1161/CIRCOUTCOMES.116.002781 – volume: 334 start-page: 983 issue: 7601 year: 2007 ident: 10727_CR34 publication-title: BMJ doi: 10.1136/bmj.39202.397488.AD – volume: 9 start-page: 929020 year: 2022 ident: 10727_CR38 publication-title: Front Cardiovasc Med doi: 10.3389/fcvm.2022.929020 – volume-title: Versorgungsatlas-Bericht year: 2021 ident: 10727_CR3 – volume: 119 start-page: 2463 issue: 18 year: 2009 ident: 10727_CR24 publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.108.825133 – volume: 4 start-page: e2113186 issue: 6 year: 2021 ident: 10727_CR39 publication-title: JAMA Netw Open doi: 10.1001/jamanetworkopen.2021.13186 – volume: 8 start-page: e020437 issue: 7 year: 2018 ident: 10727_CR19 publication-title: BMJ Open doi: 10.1136/bmjopen-2017-020437 – volume: 29 start-page: 344 issue: 2 year: 2022 ident: 10727_CR23 publication-title: Eur J Prev Cardiol doi: 10.1093/eurjpc/zwaa144 – ident: 10727_CR11 – volume: 378 start-page: 1231 issue: 9798 year: 2011 ident: 10727_CR31 publication-title: Lancet doi: 10.1016/S0140-6736(11)61215-4 – volume: 397 start-page: 2385 issue: 10292 year: 2021 ident: 10727_CR15 publication-title: Lancet doi: 10.1016/S0140-6736(21)00684-X – volume: 6 start-page: 49 issue: 3 year: 2021 ident: 10727_CR28 publication-title: J Health Monit – volume: 246 start-page: 243 year: 2016 ident: 10727_CR37 publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2016.01.018 – volume: 11 start-page: e0155228 issue: 5 year: 2016 ident: 10727_CR40 publication-title: PLoS ONE doi: 10.1371/journal.pone.0155228 – volume: 7 start-page: 39 issue: 06 year: 2014 ident: 10727_CR17 publication-title: Monit Versorgungsforschung – volume: 5 start-page: 158 year: 2018 ident: 10727_CR6 publication-title: Front Cardiovasc Med doi: 10.3389/fcvm.2018.00158 – volume: 108 start-page: 1102 issue: 10 year: 2019 ident: 10727_CR22 publication-title: Clin Res Cardiol doi: 10.1007/s00392-019-01444-8 – ident: 10727_CR20 – ident: 10727_CR5 – volume: 334 start-page: 982 issue: 7601 year: 2007 ident: 10727_CR35 publication-title: BMJ doi: 10.1136/bmj.39202.399942.AD – ident: 10727_CR1 – ident: 10727_CR26 – volume: 47 start-page: 101329 issue: 11 year: 2022 ident: 10727_CR33 publication-title: Curr Probl Cardiol doi: 10.1016/j.cpcardiol.2022.101329 – volume: 12 start-page: e005562 issue: 8 year: 2019 ident: 10727_CR29 publication-title: Circ Cardiovasc Qual Outcomes doi: 10.1161/CIRCOUTCOMES.118.005562 – volume: 396 start-page: 565 issue: 10250 year: 2020 ident: 10727_CR16 publication-title: Lancet doi: 10.1016/S0140-6736(20)31561-0 – volume: 111 start-page: 530 issue: 31–32 year: 2014 ident: 10727_CR8 publication-title: Dtsch Arztebl Int – volume: 9 start-page: e014742 issue: 11 year: 2020 ident: 10727_CR14 publication-title: J Am Heart Assoc doi: 10.1161/JAHA.119.014742 – ident: 10727_CR32 doi: 10.3390/diagnostics10070483 – ident: 10727_CR18 – volume: 328 start-page: 737 issue: 8 year: 2022 ident: 10727_CR30 publication-title: JAMA doi: 10.1001/jama.2022.12567 – volume: 40 start-page: 288 issue: 3 year: 2013 ident: 10727_CR36 publication-title: Tex Heart Inst J – volume: 21 start-page: 18 issue: 1 year: 2021 ident: 10727_CR10 publication-title: BMC Cardiovasc Disord doi: 10.1186/s12872-020-01832-3 – volume: 37 start-page: 806 issue: Suppl 3 year: 2022 ident: 10727_CR25 publication-title: J Gen Intern Med doi: 10.1007/s11606-022-07595-1 – ident: 10727_CR2 – volume: 160 start-page: 48 year: 2021 ident: 10727_CR13 publication-title: Z Evid Fortbild Qual Gesundhwes doi: 10.1016/j.zefq.2020.11.009 – ident: 10727_CR21 – volume: 13 start-page: 26 year: 2015 ident: 10727_CR7 publication-title: Popul Health Metr doi: 10.1186/s12963-015-0060-2 – volume: 60 start-page: 151 issue: 2 year: 2017 ident: 10727_CR9 publication-title: Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz doi: 10.1007/s00103-016-2493-6 – ident: 10727_CR4 – ident: 10727_CR27
SSID	ssj0017827
Score	2.3942862
Snippet	Background Coronary heart diseases (CHDs) have experienced the largest increase worldwide as a cause of death, accounting for 16% of all deaths. In... Coronary heart diseases (CHDs) have experienced the largest increase worldwide as a cause of death, accounting for 16% of all deaths. In Saxony-Anhalt, a... Background Coronary heart diseases (CHDs) have experienced the largest increase worldwide as a cause of death, accounting for 16% of all deaths. In... Abstract Background Coronary heart diseases (CHDs) have experienced the largest increase worldwide as a cause of death, accounting for 16% of all deaths. In...
SourceID	doaj pubmedcentral proquest gale pubmed crossref springer
SourceType	Open Website Open Access Repository Aggregation Database Index Database Publisher
StartPage	288
SubjectTerms	Adult Adults Cardiologic healthcare Cardiology Cardiovascular agents Coronary Disease - drug therapy Coronary Disease - epidemiology Coronary heart disease Drug therapy Evidence-based medicine Female Germany - epidemiology Health Administration Health care disparities Health care industry Health care reform Health claims data Health Informatics Heart attack Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use Male Medical research Medicine Medicine & Public Health Medicine, Experimental Nursing Research Patient compliance Public Health Quality of healthcare Risk factors Sex Characteristics Sex differences Statins Use of statins
SummonAdditionalLinks	– databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3di9QwEA9y-CCI-G31lBEEH7xy3TRJE99W8fTpEE7h3sI0TXHBS2Xbk9s_yf_SSdoe1xP0RVjYZdPSNPOZzMxvGHtFahG9q3nuqgJz4QqZmwbpV9lwR1sQsTIuNZuojo_16an5fKXVV8wJG-GBx4U7lLWRVYsrXyoUvhB1K7WRyMuyqRy2qY6cvJ55MzXFD8juVXOJjFaHPVm12MWAC1I7ZLFzsTBDCa3_T518xShdT5i8FjVNxujoLrszeZGwHmd_j93w4T67PR7BwVhZ9ID9OvEXMDdAIXUAmwAupZ8mfQcprJ4IA-lgIZ6bAfmwkDA5eohHtOAiwgFudxA7Xw8wxXPeAgb6jHgm0LUwllOC-46bsx5i2inEwhUgw69h6OibF_H5J3jRhV2-DjFMfwAfo10Iu4fs69GHL-8_5VNnhtyRzA452f3aoUeNfqUaIZxCw73TtN-tm7I1VVNpITy20qGuDd1EilF6cockb5VblY_YXuiCf8KAtIpTotVCm1aQN4OlqjX5hdoXlUKlMvZmJpT9MQJw2LRx0cqOZLVEVpvIakXG3kVaXl4ZwbPTH8RSdmIp-y-WytjryAk2ijiR2-FUqUATjmBZdl1pmZpz64ztL64k0XSL4ZczL9k4FPPZgu_Oe8uNIN9KKkHv93jkrcs5l7R02nC6Wy-4bvFSy5Gw-ZaQwSPKqyKCZuxgZlA76aT-L6v29H-s2jN2i0cBS90p99nesD33z9lN93PY9NsXSTx_A4xRPho priority: 102 providerName: Directory of Open Access Journals
Title	Sex differences in cardiologic medication provision for adults with coronary heart disease: an analysis of health claims data from 2018 to 2020 in Saxony-Anhalt, Germany
URI	https://link.springer.com/article/10.1186/s12913-024-10727-4 https://www.ncbi.nlm.nih.gov/pubmed/38448928 https://www.proquest.com/docview/2942185646 https://pubmed.ncbi.nlm.nih.gov/PMC10916020 https://doaj.org/article/5b957fa1e36a4e04bf5895a233d7caf7
Volume	24
WOSCitedRecordID	wos001188161900003&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
journalDatabaseRights	– providerCode: PRVADU databaseName: BioMedCentral customDbUrl: eissn: 1472-6963 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017827 issn: 1472-6963 databaseCode: RBZ dateStart: 20010101 isFulltext: true titleUrlDefault: https://www.biomedcentral.com/search/ providerName: BioMedCentral – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 1472-6963 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017827 issn: 1472-6963 databaseCode: DOA dateStart: 20010101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 1472-6963 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017827 issn: 1472-6963 databaseCode: M~E dateStart: 20010101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVPQU databaseName: ABI/INFORM Collection customDbUrl: eissn: 1472-6963 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017827 issn: 1472-6963 databaseCode: 7WY dateStart: 20090101 isFulltext: true titleUrlDefault: https://www.proquest.com/abicomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ABI/INFORM Global customDbUrl: eissn: 1472-6963 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017827 issn: 1472-6963 databaseCode: M0C dateStart: 20090101 isFulltext: true titleUrlDefault: https://search.proquest.com/abiglobal providerName: ProQuest – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1472-6963 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017827 issn: 1472-6963 databaseCode: 7X7 dateStart: 20090101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: Healthcare Administration Database customDbUrl: eissn: 1472-6963 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017827 issn: 1472-6963 databaseCode: M0T dateStart: 20090101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthmanagement providerName: ProQuest – providerCode: PRVPQU databaseName: Nursing & Allied Health Database customDbUrl: eissn: 1472-6963 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017827 issn: 1472-6963 databaseCode: 7RV dateStart: 20090101 isFulltext: true titleUrlDefault: https://search.proquest.com/nahs providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1472-6963 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017827 issn: 1472-6963 databaseCode: BENPR dateStart: 20090101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Publicly Available Content Database customDbUrl: eissn: 1472-6963 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017827 issn: 1472-6963 databaseCode: PIMPY dateStart: 20090101 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest – providerCode: PRVAVX databaseName: SpringerLINK Contemporary 1997-Present customDbUrl: eissn: 1472-6963 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017827 issn: 1472-6963 databaseCode: RSV dateStart: 20011201 isFulltext: true titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22 providerName: Springer Nature
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELfYhhAS4mN8FUZ1SEg8sGhp4tgOb920AQ-tqnaM8WQ5jgOVIEFNh9Y_if-SOyep6EBIIFVuVdvKx9397uzz3TH2AmHROJtFgZWhCbgNkyDNDf6K88jiEoQPUuuLTcjxWJ2fp5M2KKzuTrt3LkmP1F6slTioUTNRJYKII3Sg1g34FttBdadIHKezs7XvAHWe7MJj_jhvQwX5TP2_4_EvCunqYckrHlOviE7u_N8j3GW3W8MThg2n3GPXXLnLboxa1_ouu9Vs4EETl3Sf_Zi5S-jKpyCYwLwE6w-verQE75T3ZAW_LUG7boAWMPiMHjXQBi9Yyo9gFiugutlLaL1Br8GU-GmyoUBVQBOMCfaLmX-tgQ6tAoW9AJoNCpYVfkchXX9mLqtyFQxLcvLvwxvSKuXqAXt_cnx69DZo6zoEFiV-GaDVkFnjjDJuIHLOrTBp5KzC1XKWx0Uqc6k4d6ZIrFFZipMQVhOHxlQSFcIO4odsu6xK95gBYpIVvFBcpQVHW8jEIlNoVSoXSmGE6LFXHan1tyZ9h_bLHiV0Qw2N1NCeGpr32CFxw3okpd72f1SLT7qVZJ1kaSILM3CxMNyFPCsSlSYmiuNcWlPIHntJvKQJIJBhrGnjHPCGKdWWHkqV-NLeqsf2NkaiYNuN7ucdN2rqotNwpasuah2lHC2zRHB8vkcNd67vOcZXp9IIZ6sNvt14qM2ecv7Z5xWnHLECCdpj-x376hbR6r-8tSf_NvwpuxmRBPgqlntse7m4cM_Ydft9Oa8XfbYlp2fUfvhI7bn0reqzncPj8WTa93sm2I7CI9-eYs_k3WhCoxEEfgKZNk7j
linkProvider	Springer Nature
linkToHtml	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3ri9QwEA96igri43xVTx1B8INX7LZpHn5bxfPEu0XcU-5bSNP0bkFT2fbk9k_yv3SStos9RVBY2GWT0qYz85tJ5kXIU4RFbU2RxoYnOqYmyWNZavyVlanBLQidSBOaTfDZTBweyg99UlgzRLsPLsmA1EGsBXvRoGbynQhSitCBWjem58kFihrLB_J9nH9e-w5Q5_EhPeaP141UUKjU_zse_6KQzgZLnvGYBkW0c_3_lnCDXOsNT5h2nHKTnLNuk1za713rm-Rqd4AHXV7SLfJjbk9haJ-CYAILByYErwa0hOCUD2SFcCzhT90ALWAIFT0a8Ae8YHx9BL1cge-b3ULvDXoJ2uGnq4YCdQVdMiaYL3rxtQEftAo-7QXQbBDQ1vidJv7-c31au1U8dd7Jvw1vvVZxq9vk086bg9e7cd_XITYo8W2MVkNhtNVC2wkrKTVMy9QagbvloswqyUsuKLW6yo0WhcSLEFZzi8ZUnlbMTLI7ZMPVzt4jgJhkGK0EFbKiaAvpjBUCrUphE840YxF5PpBafevKd6iw7RFMddRQSA0VqKFoRF55bljP9KW3wx_18kj1kqzyQua80hObMU1tQosqFzLXaZaV3OiKR-SZ5yXlAQIZxug-zwEf2JfaUlMu8tDaW0RkazQTBduMhp8M3Kj8kI-Gc7Y-aVQqke9xGsX13e24c_3MGb46IVO8Woz4drSo8YhbHIe64r5GLEOCRmR7YF_VI1rzl7d2_9-mPyaXdw_299Teu9n7B-RK6qUhdLTcIhvt8sQ-JBfN93bRLB8Fsf4JJ0RH3A
linkToPdf	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3ri9QwEA96yiGIj_O1euoIgh-8crttmiZ-Wx-roi4Hq3LfQpqmuqDpse3J7Z_kf-lM2i7XUwQRCls2CW06k99MMi_GHiMsGmfzOLLZ2ETcjtNIFQbvkiK2uAXhE2VDsYlsPpeHh-rgVBR_8HbvTZJtTANlafLN_lFRtktciv0apRRVJYg5wghK4IifZxc4FQ2i_fri88aOgPIv60Nl_jhuII5C1v7fsfmUcDrrOHnGehqE0uzq_0_nGrvSKaQwbTnoOjvn_A7b_tCZ3HfY5fZgD9p4pRvs58KdQF9WBUEGlh5scGoNKArBWB_IDeG4gk7jADVjCJk-aqCDX7CUN8Gs1kD1tBvorETPwHi82iwpUJXQBmmC_WaW32sgZ1agcBhAdUJCU-FvPKbnL8xJ5dfR1JPxfw9ek7Tx65vs0-zVxxdvoq7eQ2QRCZoItYncGmekcRNRcG6FUbGzEnfReZGUKisyybkzZWqNzBUOQrhNHSpZaVwKO0lusS1feXeHAWKVFbyUXKqSo45kEpFL1DalG2fCCDFiT3uy66M2rYcO2yEpdEsNjdTQgRqaj9hz4oxNT0rJHf6oVl90t8J1mqs0K83EJcJwN-Z5mUqVmjhJisyaMhuxJ8RXmoADmceaLv4BX5hScOlpJtNQ8luO2O6gJy54O2h-1HOmpibykvOuOq51rDhqbKngOL_bLadu3jnBTydVjKPlgIcHkxq2-OXXkG-ccscKJOiI7fWsrDukq__y1e7-W_eHbPvg5Uy_fzt_d49dimkxhEKXu2yrWR27--yi_dEs69WDsMJ_AR4PUMA
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Sex+differences+in+cardiologic+medication+provision+for+adults+with+coronary+heart+disease%3A+an+analysis+of+health+claims+data+from+2018+to+2020+in+Saxony-Anhalt%2C+Germany&rft.jtitle=BMC+health+services+research&rft.au=Fleischer%2C+Steffen&rft.au=Heinrich%2C+Stephanie&rft.au=Meyer%2C+Gabriele&rft.au=Mikolajczyk%2C+Rafael&rft.date=2024-03-06&rft.pub=BioMed+Central+Ltd&rft.issn=1472-6963&rft.eissn=1472-6963&rft.volume=24&rft.issue=1&rft_id=info:doi/10.1186%2Fs12913-024-10727-4&rft.externalDocID=A785603188
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1472-6963&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1472-6963&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1472-6963&client=summon